Fruktoz; kronik hastalıklar için gizli bir tehdit

Hazır gıda üreticilerinin gittikçe artan miktarda kullandıkları mısır kaynaklı fruktoz, insan sağlığı için önemli bir tehdit haline gelmiştir. Fruktoz, meyve şekeri olarak bilinmekle birlikte, diyetteki en önemli kaynağı fruktozdan zengin mısır şurubu kullanılarak üretilen hazır gıdalardır. Fruktoz, temel olarak karaciğerde metabolize edilir ve glukoz ile aynı enerji yüküne sahiptir. Ancak glukoz gibi doyma ve tokluk hissi oluşturmaz. Bu nedenle yüksek fruktoz içeren hazır yiyecek ve içecekler doyma hissi oluşturmadıkları için daha çok tüketilirler. Son dönemde yapılan çalışmalar gıdalarla alınan fruktoz miktarı ile kalp-damar hastalıkları, tip 2 diyabet, hipertansiyon ve şişmanlık gibi metabolik hastalıklarla arasında anlamlı bir ilişki bulunduğunu göstermiştir. Halihazırda, erişkinlerin yarısından fazlasını etkileyen metabolik hastalıkların çocuklarda görülme oranı da artmaktadır. Aynı zamanda bu tür gıdalar daha çok çocuklar tarafından tüketilmektedir. Bu nedenle, metabolik hastalıkların tüm yaşlarda görülme sıklığını azaltmak için, hazır gıda ve içeceklerin fruktoz miktarı da göz önüne alınmalıdır.

Anahtar Kelimeler:

Metabolik hastalıklar, Kronik hastalık, Fruktoz, Risk faktörleri

Fructose; a hidden threat for chronic diseases

Incremental usage of the fructose derived from corn by processed-food manufacturers has become a crucial threat in terms of human health. Although it is known as fruit sugar, the most important source of dietary fructose is now, processed-food prepared by using high-fructose corn syrup. Basically, fructose is metabolized within liver and its energy load is equal to glucose. Nevertheless, it does not make up satiety and fullness. Therefore, fructose-rich foods and beverages can be consumed in large amount because the absence of satiety. Studies performed recently unveil a connection between amount of fructose consumed and metabolic disorders such as cardiovascular diseases, type 2 diabetes, hypertension and obesity. The incidence of metabolic diseases which are already affecting more than half of the adults has been increasing among children. Moreover, these types of foods are generally consumed by children. Therefore, in order to reduce the frequency of metabolic disorders in all ages, the amount of fructose in processed-foods and beverages should also be taken into consideration.

Keywords:

Metabolic Diseases, Chronic Disease, Fructose, Risk Factors,

PDF

___

1. Bhosale SH, Rao MB, Deshpande VV. Molecular and industrial aspects of glucose isomerase. Microbiol Rev. 1996; 60(2): 280-300.
2. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004; 79(4): 537-43.
3. Wolf A, Bray GA, Popkin BM. A short history of beverages and how our body treats them. Obes Rev. 2008; 9(2): 151-64.
4. Concha II, Velasquez FV, Martinez JM, Angulo C, Droppelmann A, Reyes AM, Slebe JC, Vera JC, Golde DW. Human erythrocytes express GLUT5 and transport fructose. Blood. 1997; 89(11): 4190-5.
5. Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem. 1992; 267(21): 14523-6.
6. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res. 2002; 35(1): 9-26.
7. Funari VA, Crandall JE, Tolan DR. Fructose metabolism in the cerebellum. Cerebellum. 2007; 6(2): 130-40.
8. Gonzales GF. Function of seminal vesicles and their role on male fertility. Asian J Androl. 2001; 3(4): 251-8.
9. Gonzales GF, Villena A. True corrected seminal fructose level: a better marker of the function of seminal vesicles in infertile men. Int J Androl. 2001; 24(5): 255-60.
10. Le KA, Tappy L. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care. 2006; 9(4): 469-75.
11. Macdonald I, Keyser A, Pacy D. Some effects in man, of varying the load of glucose, sucrose, fructose or sorbitol on various metabolites in blood. Am J Clin Nutr. 1978; 31(8): 1305-11.
12. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev. 2005; 63(5): 133-57.
13. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr. 1993; 58(5 Suppl): 754S-65S.
14. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr Rev. 2007; 65(6 Pt 2): 13-23.
15. Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol. 2008; 19(1): 16-24.
16. Curry DL. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas. 1989; 4(1): 2-9.
17. Schwartz MW, Woods SC, Porte D, Jr., Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000; 404(6778): 661-71.
18. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002; 13(1): 51-9.
19. Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006; 14(5): 242S-9S.
20. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY, O'Rahilly S. Partial leptin deficiency and human adiposity. Nature. 2001; 414: 34-5.
21. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda). 2007; 22: 241-51.
22. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007; 132(6): 2116-30.
23. Huda MS, Wilding JP, Pinkney JH. Gut peptides and the regulation of appetite. Obes Rev. 2006; 7(2): 163-82.
24. Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004; 89(6): 2963-72.
25. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr. 2002; 76(5): 911-22.
26. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005; 25: 391-406.
27. Isomaa B. A major health hazard: the metabolic syndrome. Life Sci. 2003; 73(19): 2395-411.
28. Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation. 2005; 112(20): 3030-2.
29. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol. 2005; 1(2): 80-6.
30. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006; 290(3): 625-31.
31. Lingelbach LB, McDonald RB. Description of the long-term lipogenic effects of dietary carbohydrates in male Fischer 344 rats. J Nutr. 2000; 130(12): 3077-84.
32. Jurgens H, Haass W, Castaneda TR, Schurmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschop MH. Consuming fructosesweetened beverages increases body adiposity in mice. Obes Res. 2005; 13(7): 1146-56.
33. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005; 2(1): 5.
34. Gaby AR. Adverse effects of dietary fructose. Altern Med Rev. 2005; 10(4): 294-306.
35. Le KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr. 2006; 84(6): 1374-9.
36. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, Sautin YY, Johnson RJ, Nakagawa T. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol. 2007; 293(4): 1256-61.
37. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol. 2007; 292(1): 423-9.
38. Sanchez-Lozada LG, Tapia E, Bautista-Garcia P, Soto V, Avila- Casado C, Vega-Campos IP, Nakagawa T, Zhao L, Franco M, Johnson RJ. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2008.
39. Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr. 2007; 137(6): 1447-54.
40. Wharton CM, Hampl JS. Beverage consumption and risk of obesity among Native Americans in Arizona. Nutr Rev. 2004; 62(4): 153-9.
41. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007; 86(4): 899-906.
42. Tam CS, Garnett SP, Cowell CT, Campbell K, Cabrera G, Baur LA. Soft drink consumption and excess weight gain in Australian school students: results from the Nepean study. Int J Obes (Lond). 2006; 30(7): 1091-3.
43. Moreno LA, Rodriguez G. Dietary risk factors for development of childhood obesity. Curr Opin Clin Nutr Metab Care. 2007; 10(3): 336-41.
44. Ochoa MC, Moreno-Aliaga MJ, Martinez-Gonzalez MA, Martinez JA, Marti A. Predictor factors for childhood obesity in a Spanish case-control study. Nutrition. 2007; 23(5): 379-84.
45. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006; 84(2): 274-88.
46. Fleischhacker S. Food fight: the battle over redefining competitive foods. J Sch Health. 2007; 77(3): 147-52.
47. Lustig RH. The 'skinny' on childhood obesity: how our western environment starves kids' brains. Pediatr Ann. 2006; 35(12): 898-902, 5-7.
48. Mello MM, Pomeranz J, Moran P. The Interplay of Public Health Law and Industry Self-Regulation: The Case of Sugar-Sweetened Beverage Sales in Schools. Am J Public Health. 2007.
49. James J, Kerr D. Prevention of childhood obesity by reducing soft drinks. Int J Obes (Lond). 2005; 29(2): S54-7.
50. Sharma M. School-based interventions for childhood and adolescent obesity. Obes Rev. 2006; 7(3): 261-9.